조아제약
034940KOSDAQ의약품 제조업45.1 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Joa Pharmaceutical, established in 1988, primarily engages in the production and sale of general pharmaceuticals, health functional foods, and is developing pet pharmaceuticals and nutritional supplements. It operates a nationwide pharmacy franchise, Medipham, and supplies over 200 products, including liver disease treatment drug Hepatos, memory improvement drug Joa Baiton, and children's health beverage Jalketon. The company has been exporting its products to 23 countries, including Vietnam, China, and the U.S., since 1995.
Number of Employees
243people
Average Salary
62.4M KRW
Score Calculation Basis
Detailed Financial Score
Higher than industry avg (caution)
Well below industry avg
2.6x industry avg (risky)
Avg ▼2.9% (2-year basis)
Avg ▼4.8% (2-year basis)
Avg ROE -28.1% (declining, 3yr)
Detailed News Sentiment
- Positive[신제품·신기술]조아제약, 7가지 복합성분 공진단 ‘몽진환 마인’
조아제약의 혁신적인 공진단 '몽진환 마인' 출시로 신제품 개발 성공과 시장 경쟁력 강화 기대.
- Positive조아제약, 일곱 가지 자연 성분 복합 환 '몽진환 마인' 출시
조아제약의 새로운 공진단 변형 제품 출시로 인해 긍정적인 시장 반응 예상.
- Positive조아제약, 5대 1 주식병합 결정
조아제약의 주식병합 결정으로 인해 주식 수가 감소하고 주당 가치 상승이 예상되어 긍정적 영향이 기대됩니다.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -27.30% (strong drop)
Volume increasing
Detailed Disclosure
- Neutral주주총회소집결의2026-05-22
- Neutral주식병합결정2026-05-22
- Neutral주주명부폐쇄기간또는기준일설정2026-05-22
- Neutral분기보고서 (2026.03)2026-05-15
